cypralis.com cypralis.com

cypralis.com

Cypralis | Novel Medicines for Degenerative Diseases

Novel Medicines for Degenerative Diseases. Discovering and developing novel medicines. For acute and chronic degenerative diseases. Cypralis is focused on the discovery and development of highly innovative therapeutics for the modulation of peptidyl-prolyl isomerases (known as PPIases). A large family of druggable protein targets known to be involved in many acute and chronic diseases. More. 44 (0)1277 367 020. Company registration no. 08028515.

http://www.cypralis.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR CYPRALIS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 10 reviews
5 star
4
4 star
3
3 star
3
2 star
0
1 star
0

Hey there! Start your review of cypralis.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.1 seconds

FAVICON PREVIEW

  • cypralis.com

    16x16

  • cypralis.com

    32x32

CONTACTS AT CYPRALIS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Cypralis | Novel Medicines for Degenerative Diseases | cypralis.com Reviews
<META>
DESCRIPTION
Novel Medicines for Degenerative Diseases. Discovering and developing novel medicines. For acute and chronic degenerative diseases. Cypralis is focused on the discovery and development of highly innovative therapeutics for the modulation of peptidyl-prolyl isomerases (known as PPIases). A large family of druggable protein targets known to be involved in many acute and chronic diseases. More. 44 (0)1277 367 020. Company registration no. 08028515.
<META>
KEYWORDS
1 jump to navigation
2 cypralis
3 about us
4 history
5 board and management
6 technology
7 ppiase
8 aims
9 mission statement
10 research portfolio
CONTENT
Page content here
KEYWORDS ON
PAGE
jump to navigation,cypralis,about us,history,board and management,technology,ppiase,aims,mission statement,research portfolio,business development,investors,collaborations,news,pipeline,contact@cypralis com
SERVER
Apache
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Cypralis | Novel Medicines for Degenerative Diseases | cypralis.com Reviews

https://cypralis.com

Novel Medicines for Degenerative Diseases. Discovering and developing novel medicines. For acute and chronic degenerative diseases. Cypralis is focused on the discovery and development of highly innovative therapeutics for the modulation of peptidyl-prolyl isomerases (known as PPIases). A large family of druggable protein targets known to be involved in many acute and chronic diseases. More. 44 (0)1277 367 020. Company registration no. 08028515.

INTERNAL PAGES

cypralis.com cypralis.com
1

Investors | Cypralis

http://www.cypralis.com/business-development/investors

Novel Medicines for Degenerative Diseases. Cypralis is a private limited liability company and is currently owned by its founder shareholders. Our strategy is to raise finance from venture capital, pharma collaborations and non-dilutive funding sources in order to achieve clinical proofs of concept in acute indications where novel PPIase-inhibitors may offer new breakthroughs for the treatment of serious hospital-based indications. Please contact us to explore opportunities for collaboration or investment.

2

Mission statement | Cypralis

http://www.cypralis.com/aims

Novel Medicines for Degenerative Diseases. Cypralis is focused on the discovery and development of highly innovative therapeutics for the modulation of peptidyl-prolyl isomerases (known as PPIases), a large family of druggable protein targets known to be involved in many acute and chronic diseases, particularly those where ischaemia, tissue necrosis, fibrosis and tissue remodelling are thought to play a major role. Please contact us to explore opportunities for collaboration or investment.

3

News | Cypralis

http://www.cypralis.com/news

Novel Medicines for Degenerative Diseases. Cypralis Limited Announces Grant Award from Alzheimer’s Drug Discovery Foundation. Cambridge, UK, 1st March 2017 / Cypralis, a life sciences company focussed on the discovery of therapeutics for the modulation of peptidyl-prolyl isomerases (PPIases), has been awarded fundin. Cypralis, Selcia and Gilead publish synthetic macrocyclic cyclophilin inhibitors inspired by natural product sanglifehrin A. Changing Shapes: From Proteins to Business Models. Cypralis, a li...

4

History | Cypralis

http://www.cypralis.com/about-us/history

Novel Medicines for Degenerative Diseases. Peptidyl-prolyl isomerases are a well conserved class of enzymes found throughout nature, in microorganisms, plants and animals. They are characterized by their ability to catalyze the interconversion of. Please contact us to explore opportunities for collaboration or investment. 44 (0)1277 367 020. Cypralis Ltd, Babraham Hall, Babraham Research Campus, Cambridge CB22 3AT, UK Tel: 44 (0)1277 367 020. Company registration no. 08028515.

5

Collaborations | Cypralis

http://www.cypralis.com/business-development/collaborations

Novel Medicines for Degenerative Diseases. Given the broad range of potential indications, Cypralis seeks to establish collaborations with pharma and biotech companies to develop PPIase inhibitors for a number of acute and chronic diseases. Please contact us to explore opportunities for potential evaluation of Cypralis compounds under MTA. Gilead Sciences, Inc. Janssen Pharmaceuticals, Inc. Please contact us to explore opportunities for collaboration or investment. 44 (0)1277 367 020.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

babraham.co.uk babraham.co.uk

Babraham Bioscience Technologies Ltd - Bioincubator Companies

http://babraham.co.uk/companies/companies.html

The Babraham Research Campus is also home to The Babraham Institute. Babraham Research Campus - Cambridge - UK. Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Their mission is to apply these technologies to create improved non-immunogenic biologics. Biosceptre International (Biosceptre UK Limited). Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic tools. Their...

babraham.com babraham.com

Babraham Bioscience Technologies Ltd - Bioincubator Companies

http://www.babraham.com/companies/companies.html

The Babraham Research Campus is also home to The Babraham Institute. Babraham Research Campus - Cambridge - UK. Antitope is pioneering a new generation of immunogenicity testing and protein engineering technologies. Their mission is to apply these technologies to create improved non-immunogenic biologics. Biosceptre International (Biosceptre UK Limited). Cambridge Epigenetix (CEGX) is a biosciences company that aims to be the world leading provider of high quality, easy to use epigenetic tools. Their...

sciad.com sciad.com

Clients | SCIAD

http://www.sciad.com/clients

The Science of Communications. Brand Strategy and Design. Who We Work With. Sciad Clients in Science, Tech and Health. Sciad works with clients offering cost-effective, direct, cutting edge online marketing techniques. Design of corporate identity, development of website, PR distribution and media liaison. Design and development of Domainex's website, digital marketing, marketing literature, PR distribution and media liaison. Sciad developed the new website for Medherant, the name of the TEPI Patch.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

3

SOCIAL ENGAGEMENT



OTHER SITES

cyprain.blogspot.com cyprain.blogspot.com

Get Academic Essays

Communication Dimension of Leadership As Service in the Church. Storytelling: Basic Element of Communication. Storytelling and Christ’s Leadership. 8221;[9] No wonder that the social teachings of the Church on communication insist that Jesus is the Perfect Communicator who demonstrates that, at its profound level, communication is more than the expression of ideas and the indication of emotion, but the giving of self in love.[10]. Conclusion: A Challenge and a Prayer. Without doubt, the foregoing poses a...

cyprainsfsermons.wordpress.com cyprainsfsermons.wordpress.com

Spirituality Stories | Stories about our spiritual journey

Stories about our spiritual journey. August 9, 2015. August 9, 2015. Creating Spiritual Community in the 21st Century. Continue reading →. August 2, 2015. August 2, 2015. A problem with white bread spirituality. Continue reading →. July 26, 2015. July 25, 2015. Following a Jesus process for conflict resolution. Continue reading →. July 12, 2015. July 12, 2015. Some days are shockers. Continue reading →. June 28, 2015. June 28, 2015. Perhaps it is love that will bring us together. Continue reading →.

cyprair-holidays.com cyprair-holidays.com

前歯だけ矯正のデメリットとは

Http:/ crd.ndl.go.jp/reference/modules/d3ndlcrdentry/index.php? Http:/ www.yokohamah.rofuku.go.jp/medical/specialty/reconstructive/. Http:/ www.jst.go.jp/pr/info/info248/.

cyprair.net cyprair.net

Domain pending ICANN verification.

This domain name is pending ICANN verification. Welcome to cyprair.net Domain name registered by 123Reg/Webfusion. Please be advised that as of the 1st January 2014 it has now become a mandatory requirement from the Internet Corporation for Assigned Name and Numbers (ICANN) that all ICANN accredited registrars verify the WHOIS contact information for all new domain registrations, domain transfers and registrant contact modifications. Why has this domain been suspended? If you have not received the verifi...

cyprairholidays.net cyprairholidays.net

Domain pending ICANN verification.

This domain name is pending ICANN verification. Welcome to cyprairholidays.net Domain name registered by 123Reg/Webfusion. Please be advised that as of the 1st January 2014 it has now become a mandatory requirement from the Internet Corporation for Assigned Name and Numbers (ICANN) that all ICANN accredited registrars verify the WHOIS contact information for all new domain registrations, domain transfers and registrant contact modifications. Why has this domain been suspended? If you have not received th...

cypralis.com cypralis.com

Cypralis | Novel Medicines for Degenerative Diseases

Novel Medicines for Degenerative Diseases. Discovering and developing novel medicines. For acute and chronic degenerative diseases. Cypralis is focused on the discovery and development of highly innovative therapeutics for the modulation of peptidyl-prolyl isomerases (known as PPIases). A large family of druggable protein targets known to be involved in many acute and chronic diseases. More. 44 (0)1277 367 020. Company registration no. 08028515.

cypram.com cypram.com

Home - Cypress Asset Management of Peoria, Illinois

Click here for more information. Cypress Asset Management is for investors who recognize and embrace the sophistication of simplicity in their investment portfolios as well as their personal lives. The irony of simplifying your investment decisions is that you’ll not only enhance your portfolio returns, you’ll also enrich your personal life with less to worry about and more time for your family and career. The Science of Investing. A State of Heart.

cypramail.com cypramail.com

Cypramail.com

This Domain Name Has Expired - Renewal Instructions.

cypramundi.blogspot.com cypramundi.blogspot.com

Cypra Mundi

Designed to give Warhammer 40,000 gamers and modelers detailed information about Forge World model kits. Monday, October 22, 2007. Marauder Destroyer Info from Mithrax. Here are some info and pics from Dakka poster Mithrax! I can't figure out how to get photos to download from Flickr (I've gotta be missing SOMETHING simple), so here's a link:. Http:/ www.flickr.com/photos/66979547@N00/sets/72157600301082754/. Here are his comments:. Parts Inventory, Cleanup. Fitting, Cutting, Sanding. 2) Minimal mold lin...

cypran.deviantart.com cypran.deviantart.com

Cypran (Ciprian Ciobanasu) - DeviantArt

Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 6 Years. This deviant's full pageview. Last Visit: 3 weeks ago. This is the place where you can personalize your profile! High five...

cypranowski.stmaryschoolmokena.org cypranowski.stmaryschoolmokena.org

Bluehost.com

There is no website configured at this address. You are seeing this page because there is nothing configured for the site you have requested. If you think you are seeing this page in error, please contact the site administrator or datacenter responsible for this site. 2003-2009 BlueHost.Com. Toll Free (888) 401-HOST(4678).